Updates from around the Mölnlycke world
Collaboration is key to our success. Explore what we’re saying, what we’re sharing and what we’re thinking.
March 17, 2020
How we handle the Covid-19 situation
Being a provider of medical devices for health care professionals – many of which are critically needed to combat the evolving COVID-19 situation –...
CEO Richard Twomey leaves Mölnlycke
Richard Twomey, President and CEO of Mölnlycke, will after six years leave the organisation.
New cost benefit analysis reports NHS chronic wound care costs can be reduced by use of haemoglobin spray
New report shows Granulox ® (Mölnlycke), an innovative topical haemoglobin spray, is a cost-effective therapy in chronic wound care management as adjunc...
September 12, 2020
WUWHS: World Union of Wound Healing Societies Congress 2020
As of 2nd of March, WUWHS has announced that the date has been rescheduled to September 13-17, 2020. Please stay tuned for more details.
January 19, 2020
Epidermolysis Bullosa (EB) World Congress 2020
19-23 January 2020, Mölnlycke will attend the 1st meeting of the Epidermolysis Bullosa (EB) World Congress in London. For 30 years, we have been driven ...
October 24, 2019
ATTWC: World Conference on Advanced Treatments & Technologies in Wound Care
It was great to meet you at the 2nd World Conference on Advanced Treatments & Technologies in Wound Care (ATTWC2019), 24-25 October 2019 in Düsseldorf,...
Mölnlycke appoints new Chief Financial Officer
With a strong track record of financial leadership in publicly listed Swedish companies Susanne Larsson will join the company as Group Chief Financial...
More than 9 in 10 surgeons encounter a needlestick injury
Global s urvey of 510 surgeons is first of its kind ; 81% believe high quality gloves impact patient outcomes ; 92% agree d that high...
Successful EMTN programme establishment and 10-year Eurobond issue for Mölnlycke
Mölnlycke, a world-leading medical solutions company, successfully launched on 28 August a EUR 500 million senior unsecured bond off its newly establish...
September 3, 2019
24th World International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Congress
Thank you for visiting us at IFEMA Palacio Municipal, Madrid, Spain last 03 - 07 September for the 24th World International Federation for the Surgery o...
Thousands of diabetic foot ulcer patients could benefit from topical oxygen therapy with updated treatment pathway
September 18, 2019
It has been great meeting you at the 21st Annual Meeting of the European Pressure Ulcer Advisory Panel (EPUAP) in Lyon,France, 18-20 September.
Mölnlycke and Zuellig Pharma strengthen partnership for advanced wound care solutions in South-East Asia
The partnership will leverage deep expertise of both companies to improve range and availability of wound care products and solutions across the region
Mölnlycke acquires patent for smart solutions to detect infection in wounds
The Swedish medical solutions company, Mölnlycke, is acquiring a patent application from Innovation Skåne, that will help detect infections in wounds....
June 5, 2019
EWMA Conference in Gothenburg
We truly enjoyed welcoming you to our home town and meeting you all at the European Wound Management Association (EWMA) Conference!
What’s next in wound management?
We explore how technology will soon be helping us manage wounds more effectively.
Introducing Healthcare Intelligence
What will healthcare look like in the next 10 years? What will it look like next year?
January 1, 2019
Mölnlycke acquires M&J Airlaid Products A/S to further strengthening its wound care capabilities
Mölnlycke, a world-leading medical products and solutions company, is pleased to announce its acquisition of M&J Airlaid Products A/S (“M&J”).
August 10, 2018
Mölnlycke at IFSO 2018 Dubai
From 26-29 September 2018, Mölnlycke was present at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic...
Mölnlycke acquires German wound care company SastoMed GmbH
The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning...
Creating opportunities at AZ BioVenture Hub
Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...
Viktiga produktlanseringar under andra kvartalet
Mölnlyckes försäljning växte under årets andra kvartal med 1 % i konstant valuta. Såväl Wound Care som Surgical växte, dock med en lägre tillväxttakt än...
Mölnlycke Holding AB (publ) EUR 350,000,000 Revolving Credit Facility
We are pleased to announce the successful closing and signing of a EUR 350,000,000 Multicurrency Revolving Credit Facility (the “Facility”) for Mölnlyck...
Media & Press
Our press room
In our press room you can find the latest press releases as well as our logotype and images for download.